MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors
Open Access
- 8 March 2021
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 191 (6), 1094-1107
- https://doi.org/10.1016/j.ajpath.2021.02.017
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund
This publication has 50 references indexed in Scilit:
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells*Online Journal of Public Health Informatics, 2012
- Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass AccumulationPLOS ONE, 2011
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell LinesMolecular Cancer Therapeutics, 2011
- siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate CancerPLOS ONE, 2011
- Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genesEpigenetics, 2010
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule InhibitorCell Chemical Biology, 2010
- Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate CancerClinical Cancer Research, 2010
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005